Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Summons to bondholders’ meetings

Bonheur ASA has called for bondholders' meetings for the bond issues "BON06" (ISIN NO0010714538), "BON07" (ISIN NO0010793565) and "BON08" (ISIN NO0010809577) to harmonize the equity ratio definition with the newly issued BON 09 (ISIN NO0010861313). The bondholders’ meetings will be held on 14 November 2019 at 13:00. Please see the attachment for further information. For questions, please contact: Bonheur ASA Øyvind B. Kristiansen, Fred. Olsen & Co., +47 90 01 05 29 or oyvind.kristiansen@fredolsen.com Haakon Magne Ore, Fred. Olsen & Co., +47 92 02 75 10 or hmore@fredolsen.com

Number of shares and votes in Medicover

The number of votes in Medicover AB (publ) (“Medicover ”) has changed as a result of conversions of in total 5,065 class A shares into class B shares carried out in October following requests from shareholders in accordance with the conversion clause in Medicover’s articles of association. Today, the last trading day of the month, there are in total 135,735,195 shares in Medicover, of which 78,796,431 are class A shares, together carrying 78,796,431 votes, 54,538,764 are class B shares, together carrying 5,453,876.4 votes and 2,400,000 are class C shares,

Managers’ transactions

Nordea Bank Abp – Stock exchange release – Managers’ transactions Transaction notification under Article 19 of the EU Market Abuse Regulation Person subject to the notification requirementName: Steen, BirgerPosition: Member of the Board of DirectorsIssuer: Nordea Bank AbpLEI: 529900ODI3047E2LIV03 Notification type: Initial NotificationReference number: 529900ODI3047E2LIV03_20191029152403_2 Transaction date: 2019-10-29Venue: OFF-EXCHANGE TRANSACTIONS (XOFF)Instrument type: SHAREISIN: FI4000297767Nature of the transaction: Acquisition    Transaction details

Invitation to Alfa Laval’s Capital Markets Day, December 5

Alfa Laval invites analysts, professional investors and media to its Capital Markets Day, which will be held on December 5 at Malmö Arena Hotel, Hyllie Boulevard 12, Malmö, Sweden. It will start at 11:00 CET and end at approximately 16:00 CET. For those of you arriving to Copenhagen Airport, we will offer a shuttle from the airport to Malmö Arena Hotel, just a 15 minutes ride to the other side of the bridge between Denmark and Sweden. The first part will include presentations by Jan Allde, CFO and Mikael Tydén, Head of Operations. This contains an update on the larger investment programs

Nomination Committee for Duni’s AGM 2020

Pursuant to a resolution adopted at Duni’s Annual General Meeting in 2019, a Nomination Committee has been appointed prior to the Annual General Meeting in 2020. Duni hereby announces the composition of the Nomination Committee.The following persons will serve on the Nomination Committee, which is charged with presenting proposals to the Annual General Meeting in 2020 regarding the composition of Duni’s Board of Directors, etc.: Mr Johan Andersson, Mellby Gård Investerings ABMr John Strömgren, Carnegie fonderMr Bernard R. Horn, Jr., Polaris Capital Management, LLCMr Magnus Yngen,

Metsä Wood awards Estonian start-up Team 99 for an eco-friendly modular design

Metsä Wood, a Finnish engineered wood product company, has awarded the Estonian start-up Team 99 for its innovative design of a module that can be used to construct buildings of different sizes and shapes, at the same time reducing their overall carbon footprint. The module has been completely designed using Metsä Wood’s Kerto LVL (laminated veneer lumber) products – making the design fast, light and green. The awarded design was one of the outcomes of the wood hackathon Future of Wood, organised by the Academy of Art and Garage 48 in Tallinn. The event, which attracted about 100

Capital increase in TORM due to exercise of Restricted Share Units

TORM plc (“TORM”) will increase its share capital by 42,533 A-shares (corresponding to a nominal value of USD 425.33) as a result of the exercise of a corresponding number of Restricted Share Units. The capital increase will be carried out without any pre-emption rights for existing shareholders or others. The new shares have been subscribed for in cash at DKK 53.7 per A-share with a nominal value of USD 0.01 each. The new shares are ordinary shares without any special rights and are negotiable instruments. The new shares will be freely transferable on Nasdaq in Copenhagen, but

Telephone conference Actic’s interim report Q3 2019

Actic’s interim report for the first nine months 2019 will be published on Wednesday 6 November at 07:45 am CET. A telephone conference will be held at 10:00 am CET on the same day, where CEO Anders Carlbark and CFO Jörgen Fritz comments on the report. The telephone number is +46 8 229090 and the code 426565#. Before the conference a presentation will be published on: www.acticgroup.com For further information, please contact: Jörgen Fritz, CFO, jorgen.fritz@actic.se, +46 73 663 54 74

Invitation to a teleconference and audiocast in connection with Arise´s Q3-report for 2019

Arise’s Q3-report for 2019 will be released on Friday 8 November, 2019 at around 08.00 CET. At 11.00 on the same day a teleconference will be held, hosted by Daniel Johansson, CEO and Linus Hägg, CFO, who will present the report to the stock market and media. After the presentation those attending will be invited to ask questions. The dial in number for the conference call is: Sweden:                                           +46 8 566 426 95 UK:                                                   +44 33 330 092 72 During the teleconference a presentation will be held. To

Conversion of shares

According to Husqvarna AB´s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in Husqvarna AB. When such a conversion has occurred, the company is obligated by the Act on Trading in Financial Instruments to disclose any such change. In October 2019, at the request of shareholders, 200 Class A shares were converted to Class B shares. The total number of votes thereafter amounts to 158,448,443.9. The total number of registered shares in the company amounts to 576,343,778 shares

Karnov’s Nomination Committee appointed

Karnov Group AB (Nasdaq: KAR), the leading Nordic legal-information provider, has appointed its Nomination Committee for the Annual General Meeting 2020 in accordance with the Instruction for the Nomination Committee.The Nomination Committee consists of:  • Sacha Oshry, Director, Rothschild & Co, Five Arrows Principal Investments, U.K. • Christian Petersen, Operating Executive, Vind LV AS, Norway • Thomas Ehlin, Corporate Governance, Fourth National Pension Fund, Sweden and • Magnus Mandersson, Chairman of the Board of Directors, Karnov Group AB. Mr. Sacha Oshry is the

Invitation to Eltel’s third quarter 2019 interim report presentation

Eltel will publish its interim report for the third quarter 2019 on Thursday 7 November 2019 at approximately 08.00 am CET. Eltel’s CEO Casimir Lindholm and CFO Petter Traaholt will host a presentation via audiocast in English starting at 10.00 am CET.The presentation will be audiocasted live on www.eltelgroup.com. For those who would like to participate in the telephone conference in connection with the presentation, the telephone numbers are: ·  SE: +46 8 5199 9383 ·  FI: +358 9 8171 0522 ·  UK: +44 33 3300 9270 Please, call well in advance to register. After the

Karolinska University Hospital participates as the only Swedish hospital in a global clinical CAR T-cell study for treatment of aggressive lymphoma. First adult patient has been treated at Karolinska

On August 27, 2019, the first patient in Sweden, and the third in Europe, was treated with genetically modified CAR-T cells as part of the TRANSFORM study at Karolinska University Hospital Huddinge at the Department of Cell Therapy and Allogeneic Stem Cell Transplant (CAST). The treatment is conducted within the framework of a randomized clinical trial that offers either standard autologous stem cell transplantation therapy or experimental treatment with CD19-CAR-Tcells (JCAR17).The patient included in the study has been diagnosed with a relapse of an aggressive form of lymphoma included in

Lack of alignment between business goals and quality ambitions impedes Agile and DevOps adoption

The World Quality Report also reveals skills and security challenges as major hindrances for organizations to uplift their testing and IT environment.Paris, October 31, 2019 – The World Quality Report  2019-20 (WQR), released today by Capgemini and Sogeti, part of the Capgemini Group, and published in conjunction with Micro Focus , shows alignment with business priorities and customer

Tikkurila Color of the Year 2020: When life gives you lemons, make lemonade

Tikkurila's color of the year is H300 Lemonade, which represents positivity and optimism. The color and color collection of the year invites you to look on the bright side of life. Tikkurila’s H300 Lemonade is a continuation of the yellow trend that has been seen in fashion and decor. At the same time, it is bright and soft, energizing and sophisticated – a delightful shade to replace everyday grey and beige. H300 Lemonade is a breath of fresh air and reminds us of the power of positivity. There is always a flash of light somewhere, there is always the opportunity for change – both at

Navamedic ASA shares: Last day of trading inclusive of rights to consideration shares in Observe Medical ASA

Navamedic ASA, 31 October 2019: The shares in Navamedic ASA (the "Company" or "NAVA") will today on Thursday 31 October 2019 for the last day trade inclusive of rights to consideration shares in Observe Medical ASA ("Observe Medical") to be distributed in connection with the demerger of NAVA. The demerger, whereby inter alia NAVA's Medtech division is demerged from NAVA and merged into Observe Medical against distribution of the shares in Observe Medical to the existing shareholders of NAVA, was approved by the general meetings of the Company and Observe Medical on 5 August 2019. The

Navamedic ASA shares: Last day of trading inclusive of rights to consideration shares in Observe Medical ASA

Navamedic ASA, 31 October 2019: The shares in Navamedic ASA ("NAVA") will today on Thursday 31 October 2019 for the last day trade inclusive of rights to consideration shares in Observe Medical ASA ("Observe Medical") to be distributed in connection with the demerger of NAVA. The demerger, whereby inter alia NAVA's Medtech division is demerged from NAVA and merged into Observe Medical against distribution of the shares in Observe Medical to the existing shareholders of NAVA, was approved by the general meetings of NAVA and Observe Medical on 5 August 2019. The creditor notice period for

Efficient workflow and AI platform grants Sectra enterprise imaging contract at prominent Dutch university hospital

Linköping, Sweden – October 31, 2019 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a five-year contract for its enterprise imaging solution with the Dutch University Medical Center Groningen (UMCG). With the solution, image handling across the hospital will be consolidated to a single solution. It allows for more efficient access and collaboration around patient images and reduces cost and workload for the IT department.With over 12,000 employees, UMCG is one of the largest hospitals in the Netherlands. As a university

STENOCARE CEO looks ahead after the first year as a listed company

CEO of STENOCARE A/S (“STENOCARE”), Thomas Schnegelsberg, reflects on the first 12 months as a public company and looks ahead to what he calls STENOCARE 2.0 and beyond:THE FIRST 12 MONTHS – ALL TARGETS MET It was a proud moment when we could ring the bell and start trading on the 26th of October 2018 as the first ever IPO of a licensed provider of medical cannabis in Europe. Looking back, I am pleased to say that since then we have met or exceeded our short-term objectives. First mover: We were the first company to secure all required licenses for cultivating and import of medical

Tecnotree Board of Directors approves the Long Term Incentive (LTI) plan for 2019-2022 and the issuance of shares to Tecnotree; Board of Directors resolves upon a directed share issue to CEO

Tecnotree announced today that its Board of Directors has approved the company's employee incentive program for 2019-2022 (the "LTI Plan") designed to align the participants' focus with Tecnotree’s growth strategy and long-term success. The LTI Plan includes the following instrument: · Restricted Share Units (RSUs) giving a contractual right to receive shares over the next 3 year period as per an equated semi-annual vesting schedule. LTI Plan Objective Having shown recovery from a difficult period where bonus pay-outs and salary increments were suspended for the key employees and

Management change at Catena

Catena appoints Sofie Bennsten as Deputy CEO and CFO. Sofie will succeed the current Deputy CEO and CFO, Peter Andersson, who has expressed his desire to reduce his current involvement following many successful years in this position. Peter will continue to be involved in Catena in a new role as Head of Treasury. In connection with this change, Jörgen Eriksson, Regional Manager Malmö, will be appointed Deputy CEO of the company. All of these management changes will be implemented at the end of April 2020.31 October 2019, 8:45 a.m. CET Sofie Bennsten has most recently been employed in the

Year-end report 2018-09-01 - 2019-08-31

Nextcell Pharma AB ("NXTCL") today announces the year-end report for the 2018/2019 fiscal year (2018-08-31 2019-08-31)Twelve months (2018-09-01 until 2019-08-31) · Operating income amounted to SEK 1 964 132 (655 413). · Operating result amounted to SEK -21 450 784 (-14 032 294).                · Earnings per share* amounted to SEK -1.36 (-0.61). · Cash and bank amounted to SEK 20 128 185 (3 115 876). · Solidity** amounted to 85.9 (59.2) %. Fourth quarter (2019-06-01 until 2019-08-31) · Operating income amounted to SEK 551 708 (127 868). · Operating result

Invitation to presentation in conjunction with Net Gaming's third quarter of 2019

On Thursday 14 November at 08:30 a.m. CET Net Gaming's interim report for the third quarter of 2019 will be published. At 10:00 a.m. the same day a presentation of Net Gaming's interim report for the third quarter of 2019, will be presented.CEO Marcus Teilman and CFO Gustav Vadenbring will present the results, followed by a Q&A session. The presentation will be held in English and will be webcasted live through netgaming.se or via https://tv.streamfabriken.com/net-gaming-europe-q3-2019 The join the conference via phone, please dial-in using any of the numbers below: From Sweden:

There are no items matching the current filter
There are no more items matching the current filter
Back to top